| • |
InSight launches HepAnalyze - a novel Heparanase ELISA kit for quantitative measurement of human Heparanase in plasma and urine
July 11, 2010
InSight has launched today a new addition to its broad line of research tools, aiming at intensifying Heparanase research as a basis for the development of new drugs and diagnostics. |
| |
|
| • |
In-SiteTM: A novel site-selective PEGylation platform announced by InSight Biopharmaceuticals Ltd.
August 6, 2008
InSight announces today that it has developed a novel, selective and efficient PEGylation technology, termed In-SiteTM PEGylation, which is applicable to a large variety of important therapeutic proteins.
|
| |
|
| • |
InSight Launches HepActiv - a novel Heparanase activity assay kit
December 19, 2007
InSight has launched today a new research tool, aiming at intensifying heparanase research as a basis for the development of new drugs and diagnostics. |
| |
|
| • |
Anti-Heparanase Antibodies Show Promise in Predictive Cancer Diagnostics
September 4, 2005
A Recent Study Using InSight's Anti-Heparanase Mabs Provides First Clinical Demonstration for Heparanase as a Useful Marker to Predict Response to Palliative Chemotherapy in Pancreatic Ductal Adenocarcinoma |
| |
|
| • |
A New Article by InSight Describes Heparanase's Wound Healing Activity
January 30, 2005
The recent published results indicate that elevation of Heparanase levels in healing wounds markedly accelerate tissue repair and skin survival |
| |
|
| • |
InSight to Attend ICSE/CPhI 2004
October 14, 2004
The Company promotes its first to market generic version of interferon beta-1a API and its novel technology for the improvement of cell therapy procedures |
| |
|
| • |
New Patent Granted to InSight for Antisense Oligonucleotides Inhibition of Heparanase
January 26, 2004
Newly Patented Technology Opens the Door for the Development of Novel Cancer Therapy Approaches
|
| |
|
